DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 62701 - 62725 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID ▼ Gene Name UniProt ID
C0233794 Memory impairment GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0279702 Conventional (Clear Cell) Renal Cell Carcinoma GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0019294 Hernia, Inguinal GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0497327 Dementia GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0040034 Thrombocytopenia GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0235974 Pancreatic carcinoma GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0027868 Neuromuscular Diseases GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0686353 Muscular Dystrophies, Limb-Girdle GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0006826 Malignant Neoplasms GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0751713 Inclusion Body Myopathy, Sporadic GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0241005 Creatine phosphokinase serum increased GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C1839615 X-linked myopathy with excessive autophagy GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0878544 Cardiomyopathies GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C1263846 Attention deficit hyperactivity disorder GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0027121 Myositis GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C1833662 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0345905 Intrahepatic Cholangiocarcinoma GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0238190 Inclusion Body Myositis (disorder) GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0086795 Pfaundler-Hurler Syndrome GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0020676 Hypothyroidism GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0017168 Gastroesophageal reflux disease GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0002395 Alzheimer's Disease GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0037315 Sleep Apnea Syndromes GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0008350 Cholelithiasis GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0007134 Renal Cell Carcinoma GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024